CN115400199A - Traditional Chinese medicine composition for treating liver-stagnation and spleen-deficiency type insomnia and preparation thereof - Google Patents
Traditional Chinese medicine composition for treating liver-stagnation and spleen-deficiency type insomnia and preparation thereof Download PDFInfo
- Publication number
- CN115400199A CN115400199A CN202211125375.1A CN202211125375A CN115400199A CN 115400199 A CN115400199 A CN 115400199A CN 202211125375 A CN202211125375 A CN 202211125375A CN 115400199 A CN115400199 A CN 115400199A
- Authority
- CN
- China
- Prior art keywords
- parts
- liver
- rhizoma
- radix
- insomnia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 title claims abstract description 97
- 206010022437 insomnia Diseases 0.000 title claims abstract description 95
- 239000003814 drug Substances 0.000 title claims abstract description 86
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims description 15
- 210000004185 liver Anatomy 0.000 claims abstract description 81
- 210000000952 spleen Anatomy 0.000 claims abstract description 56
- 230000007812 deficiency Effects 0.000 claims abstract description 51
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 33
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 32
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 32
- 244000197580 Poria cocos Species 0.000 claims abstract description 25
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 25
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 24
- 235000008397 ginger Nutrition 0.000 claims abstract description 24
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 20
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 20
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 17
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 17
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 17
- 241000132012 Atractylodes Species 0.000 claims abstract description 15
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 12
- 235000018958 Gardenia augusta Nutrition 0.000 claims abstract description 9
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 61
- 238000001914 filtration Methods 0.000 claims description 23
- 239000000843 powder Substances 0.000 claims description 22
- 238000005303 weighing Methods 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 21
- 238000000605 extraction Methods 0.000 claims description 20
- 239000007921 spray Substances 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 16
- 241000382455 Angelica sinensis Species 0.000 claims description 14
- 239000008187 granular material Substances 0.000 claims description 14
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 13
- 210000000582 semen Anatomy 0.000 claims description 13
- 238000001694 spray drying Methods 0.000 claims description 13
- 229920001353 Dextrin Polymers 0.000 claims description 9
- 239000004375 Dextrin Substances 0.000 claims description 9
- 235000019425 dextrin Nutrition 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 244000061520 Angelica archangelica Species 0.000 claims description 8
- 241000202726 Bupleurum Species 0.000 claims description 8
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 8
- 238000009472 formulation Methods 0.000 claims description 7
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims description 6
- 244000236658 Paeonia lactiflora Species 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 3
- 244000164480 Curcuma aromatica Species 0.000 claims 1
- 235000003398 Curcuma aromatica Nutrition 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 33
- 210000004369 blood Anatomy 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 13
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract description 9
- 238000005728 strengthening Methods 0.000 abstract description 3
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 230000001976 improved effect Effects 0.000 description 65
- 208000024891 symptom Diseases 0.000 description 58
- 230000007958 sleep Effects 0.000 description 39
- 238000003745 diagnosis Methods 0.000 description 33
- 238000012360 testing method Methods 0.000 description 32
- 230000002618 waking effect Effects 0.000 description 30
- 239000011248 coating agent Substances 0.000 description 28
- 238000000576 coating method Methods 0.000 description 28
- 239000000284 extract Substances 0.000 description 26
- 229940079593 drug Drugs 0.000 description 25
- 206010016256 fatigue Diseases 0.000 description 23
- 238000001035 drying Methods 0.000 description 21
- 230000027939 micturition Effects 0.000 description 20
- 208000002173 dizziness Diseases 0.000 description 19
- 208000019116 sleep disease Diseases 0.000 description 19
- 241000234314 Zingiber Species 0.000 description 18
- 239000006071 cream Substances 0.000 description 17
- 206010022998 Irritability Diseases 0.000 description 14
- 241000699670 Mus sp. Species 0.000 description 13
- 210000003141 lower extremity Anatomy 0.000 description 13
- 238000002791 soaking Methods 0.000 description 13
- 206010000060 Abdominal distension Diseases 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 12
- 230000036528 appetite Effects 0.000 description 12
- 235000019789 appetite Nutrition 0.000 description 12
- 206010013781 dry mouth Diseases 0.000 description 12
- 210000003414 extremity Anatomy 0.000 description 12
- 206010033557 Palpitations Diseases 0.000 description 11
- 238000007908 dry granulation Methods 0.000 description 11
- 239000002245 particle Substances 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 206010013954 Dysphoria Diseases 0.000 description 10
- 206010037660 Pyrexia Diseases 0.000 description 10
- 208000009205 Tinnitus Diseases 0.000 description 10
- 238000004140 cleaning Methods 0.000 description 10
- 239000012535 impurity Substances 0.000 description 10
- 230000035807 sensation Effects 0.000 description 10
- 235000019615 sensations Nutrition 0.000 description 10
- 231100000886 tinnitus Toxicity 0.000 description 10
- 208000019914 Mental Fatigue Diseases 0.000 description 9
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 241001106477 Paeoniaceae Species 0.000 description 8
- 238000001704 evaporation Methods 0.000 description 8
- 238000005469 granulation Methods 0.000 description 8
- 230000003179 granulation Effects 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 206010020772 Hypertension Diseases 0.000 description 7
- 208000006083 Hypokinesia Diseases 0.000 description 7
- 241001522232 Pinellia ternata Species 0.000 description 7
- 235000019658 bitter taste Nutrition 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 206010013789 Dry throat Diseases 0.000 description 6
- 206010067125 Liver injury Diseases 0.000 description 6
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 6
- 235000001188 Peltandra virginica Nutrition 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 238000007596 consolidation process Methods 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
- 210000003127 knee Anatomy 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 229940118019 malondialdehyde Drugs 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 6
- 102000012440 Acetylcholinesterase Human genes 0.000 description 5
- 108010022752 Acetylcholinesterase Proteins 0.000 description 5
- 244000163122 Curcuma domestica Species 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 206010024642 Listless Diseases 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 102000019197 Superoxide Dismutase Human genes 0.000 description 5
- 108010012715 Superoxide dismutase Proteins 0.000 description 5
- 229940022698 acetylcholinesterase Drugs 0.000 description 5
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 5
- 229960003529 diazepam Drugs 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 210000000232 gallbladder Anatomy 0.000 description 5
- 210000003128 head Anatomy 0.000 description 5
- 238000011835 investigation Methods 0.000 description 5
- 208000017971 listlessness Diseases 0.000 description 5
- 230000036565 night sweats Effects 0.000 description 5
- 206010029410 night sweats Diseases 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- 208000000044 Amnesia Diseases 0.000 description 4
- 208000031091 Amnestic disease Diseases 0.000 description 4
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 4
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 4
- 235000003392 Curcuma domestica Nutrition 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 241000555712 Forsythia Species 0.000 description 4
- 102000015779 HDL Lipoproteins Human genes 0.000 description 4
- 108010010234 HDL Lipoproteins Proteins 0.000 description 4
- 206010062519 Poor quality sleep Diseases 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000006986 amnesia Effects 0.000 description 4
- 230000001430 anti-depressive effect Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 235000003373 curcuma longa Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000971 hippocampal effect Effects 0.000 description 4
- 238000011031 large-scale manufacturing process Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 208000013220 shortness of breath Diseases 0.000 description 4
- 230000004622 sleep time Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 235000013976 turmeric Nutrition 0.000 description 4
- 241000233788 Arecaceae Species 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 240000001972 Gardenia jasminoides Species 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- KYWSCMDFVARMPN-LCSVLAELSA-N Saikosaponin D Chemical compound O([C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(C[C@@H](O)[C@]67CO[C@]5([C@@H]6CC(C)(C)CC7)C=C4)C)(C)CC3)(C)CC2)(C)CO)O[C@@H]([C@@H]1O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KYWSCMDFVARMPN-LCSVLAELSA-N 0.000 description 3
- 206010047513 Vision blurred Diseases 0.000 description 3
- 231100000439 acute liver injury Toxicity 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 230000003394 haemopoietic effect Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 231100000753 hepatic injury Toxicity 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000011477 liquorice Nutrition 0.000 description 3
- 210000005228 liver tissue Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000002633 protecting effect Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- QLPRYZXNWYTFCI-UHFFFAOYSA-N saikosaponin D Natural products CC1OC(OC2CCC3(C)C(CCC4(C)C3C=CC56OCC7(CCC(C)(C)CC57)C(O)CC46C)C2(C)CO)C(O)C(O)C1OC8OC(CO)C(O)C(O)C8O QLPRYZXNWYTFCI-UHFFFAOYSA-N 0.000 description 3
- PQPVAGWUNWFCJE-UHFFFAOYSA-N saikosaponin a Natural products CC1OC(OC2CCC3(C)C(C2)C(C)(CO)CC4(C)C3C=CC56OCC7(CCC(C)(C)CC57)C(O)CC46C)C(O)C(OC8OC(CO)C(O)C(O)C8O)C1O PQPVAGWUNWFCJE-UHFFFAOYSA-N 0.000 description 3
- 230000003860 sleep quality Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 240000007185 Albizia julibrissin Species 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 108010058699 Choline O-acetyltransferase Proteins 0.000 description 2
- 102100023460 Choline O-acetyltransferase Human genes 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 241000581650 Ivesia Species 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 2
- 241001522129 Pinellia Species 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 2
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 2
- 240000008866 Ziziphus nummularia Species 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001713 cholinergic effect Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 206010029446 nocturia Diseases 0.000 description 2
- 238000000643 oven drying Methods 0.000 description 2
- 229960002275 pentobarbital sodium Drugs 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 2
- 229960003147 reserpine Drugs 0.000 description 2
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000007779 soft material Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- HTIQEAQVCYTUBX-KRWDZBQOSA-N (S)-amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-KRWDZBQOSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- JYGXADMDTFJGBT-MKIDGPAKSA-N 11alpha-Hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-MKIDGPAKSA-N 0.000 description 1
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 1
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 1
- 240000000559 Albizia odoratissima Species 0.000 description 1
- 235000011438 Albizia odoratissima Nutrition 0.000 description 1
- 241000605445 Anemarrhena asphodeloides Species 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000004130 Blepharoptosis Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 241000963390 Curcuma wenyujin Species 0.000 description 1
- 235000003394 Curcuma wenyujin Nutrition 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010015967 Eye swelling Diseases 0.000 description 1
- 206010015995 Eyelid ptosis Diseases 0.000 description 1
- 241001312741 Gekko swinhonis Species 0.000 description 1
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 1
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000020358 Learning disease Diseases 0.000 description 1
- 241000112528 Ligusticum striatum Species 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 244000182807 Mentha suaveolens Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241001479543 Mentha x piperita Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000003979 Mineralocorticoid Receptors Human genes 0.000 description 1
- 108090000375 Mineralocorticoid Receptors Proteins 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000007072 Nerve Growth Factors Human genes 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 240000002924 Platycladus orientalis Species 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 235000008109 Thuja occidentalis Nutrition 0.000 description 1
- 240000003243 Thuja occidentalis Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000023505 abnormal feces Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003282 amino acid receptor affecting agent Substances 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 description 1
- 208000027687 belching Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 239000002729 catgut Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 210000001787 dendrite Anatomy 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 108010012204 glutamate aminotransferase Proteins 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 210000004295 hippocampal neuron Anatomy 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 229940053999 hypnotics and sedatives melatonin receptor agonists Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 201000003723 learning disability Diseases 0.000 description 1
- 229950008554 levamlodipine Drugs 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 239000001771 mentha piperita Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000003900 neurotrophic factor Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000004983 pleiotropic effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 201000003004 ptosis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000037983 regulatory factors Human genes 0.000 description 1
- 108091008025 regulatory factors Proteins 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000008786 sensory perception of smell Effects 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating liver depression and spleen deficiency type insomnia, which comprises the following components in parts by weight: 200 to 250 parts of radix bupleuri, 125 to 175 parts of Chinese angelica, 125 to 175 parts of white paeony root, 100 to 150 parts of mint, 125 to 175 parts of radix curcumae, 225 to 275 parts of cortex albiziae, 275 to 325 parts of poria cocos, 200 to 250 parts of bighead atractylodes rhizome, 200 to 250 parts of rhizoma pinellinae praeparata, 125 to 175 parts of ginger, 125 to 175 parts of cape jasmine, 125 to 175 parts of rhizoma anemarrhenae, 125 to 175 parts of fructus forsythiae, 275 to 325 parts of spina date seed, 225 to 275 parts of platycladi seed and 100 to 150 parts of honey-fried licorice root. The invention has the effects of soothing liver, strengthening spleen, clearing heart and nourishing heart, mainly clears stagnated fire of heart and liver, and nourishes yin and blood of heart and liver, and can be used for treating liver stagnation and spleen deficiency type insomnia.
Description
Technical Field
The invention belongs to the field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating liver depression and spleen deficiency type insomnia and a preparation thereof.
Background
Insomnia usually means that the sleep time and depth are insufficient, the patient is not easy to fall asleep, the patient is difficult to fall asleep again after waking, and even the patient does not sleep all night, so that normal work, study, life and health are affected.
The factors causing insomnia are many, are usually complicated by multiple causes and can be generally divided into primary insomnia and secondary insomnia, the secondary insomnia is caused by various mental diseases, single-system or multi-system body diseases and inaccurate medication, the knowledge of students on the primary insomnia causes is not unified, and the pathogenesis is mainly related to the hypothalamus-pituitary-adrenal axis hyperactivity of a stress heatstroke system, the functional hypofunction of the brain central gamma-aminobutyric acid neuron system and the like.
The clinical treatment of insomnia is mainly based on drug therapy, and the clinically common drug types are melatonin, melatonin receptor agonists and the like. According to the traditional Chinese medicine, insomnia belongs to the category of insomnia, doctors of different generations summarize that people have excess of five emotions, incoordination between the spleen and the stomach, overstrain and malaise degree, pathogenic qi infection or consumptive disease after illness and the like according to years of clinical experience, the treatment method is mainly based on an internal treatment method and an external treatment method, and through Chinese herbal medicines, acupuncture, catgut embedding, massage and other methods, the opposition and restriction of five internal organs are balanced, and the abundance and insufficiency of yin and yang of ying and wei are saved.
In modern society, the imbalance of the structure and the law of food and drink often occurs when the pressure of work and study is increased, people worry too much and desire too much or are difficult to meet basic appeal, meanwhile, spleen soil cannot obtain sufficient nutrition and is weak, spleen qi is added in pairs, the spleen qi cannot transport and transform the body fluid, and the body fluid cannot be carried and distributed, so that the yin and yang of the body are disharmony to cause insomnia. For insomnia caused by liver depression and spleen deficiency, the disease is located in the liver and spleen, and how to sooth the liver and strengthen the spleen by planting herbal medicines is an urgent problem to be solved.
Disclosure of Invention
The invention aims to provide a traditional Chinese medicine composition for treating liver depression and spleen deficiency type insomnia and a preparation thereof, wherein the traditional Chinese medicine composition has the functions of soothing liver, strengthening spleen, clearing heart and nourishing heart, mainly clears away stagnated fire of heart and liver and supplements yin and blood of heart and liver.
The invention adopts the following technical scheme:
a traditional Chinese medicine composition for treating liver depression and spleen deficiency type insomnia comprises the following components in parts by weight: 200 to 250 portions of bupleurum, 125 to 175 portions of angelica, 125 to 175 portions of white peony root, 100 to 150 portions of mint, 125 to 175 portions of curcuma, 225 to 275 portions of cortex albiziae, 275 to 325 portions of tuckahoe, 200 to 250 portions of atractylodes, 200 to 250 portions of rhizoma pinellinae praeparata, 125 to 175 portions of ginger, 125 to 175 portions of gardenia, 125 to 175 portions of rhizoma anemarrhenae, 125 to 175 portions of forsythia, 275 to 325 portions of spina date seed, 225 to 275 portions of platycladi seed and 100 to 150 portions of honey-fried licorice root.
Further, the paint comprises the following components in parts by weight: 225 parts of radix bupleuri, 150 parts of angelica, 150 parts of white peony root, 125 parts of mint, 150 parts of radix curcumae, 250 parts of cortex albiziae, 300 parts of poria cocos, 225 parts of bighead atractylodes rhizome, 225 parts of rhizoma pinellinae praeparata, 150 parts of ginger, 150 parts of cape jasmine fruit, 150 parts of rhizoma anemarrhenae, 150 parts of fructus forsythiae, 300 parts of spina date seed, 250 parts of platycladi seed and 125 parts of radix glycyrrhizae preparata.
Further, it is prepared by the following method:
(1) Weighing the medicinal materials according to the weight ratio;
(2) Decocting radix bupleuri, angelica sinensis, radix paeoniae alba, radix curcumae, cortex albiziae, poria cocos, bighead atractylodes rhizome, rhizoma pinellinae praeparata, ginger, gardenia, rhizoma anemarrhenae, fructus forsythiae, spina date seed, platycladi seed and radix glycyrrhizae preparata with 6 times of water, adding mint when extracting for 100-110 minutes, extracting for 10-20 minutes, and filtering;
(3) Adding 6 times of water into the solid filtered in the step (2) for decoction, extracting for 85-95 minutes, and filtering;
(4) Combining the filtrates in the step (2) and the step (3), and concentrating under reduced pressure to obtain clear paste with the relative density of 1.05-1.16;
(5) And spray drying the clear paste to obtain spray dry powder.
In the preparation method, the step (2) is that the bupleurum, the angelica, the white paeony root, the turmeric root-tuber, the albizia bark, the tuckahoe, the largehead atractylodes rhizome, the rhizoma pinellinae praeparata, the ginger, the gardenia, the rhizoma anemarrhenae, the forsythia, the spina date seed, the platycladi seed and the honey-fried licorice root are added with 6 times of water for decoction, the mint is added when the extraction is carried out for 105 minutes, the extraction is carried out for 15 minutes, and the filtration is carried out.
In the preparation method, the step (3) is to take the solid filtered in the step (2) and add 6 times of water for decoction, extract for 90 minutes and filter.
In the preparation method, in the step (4), the vacuum degree of the reduced pressure concentration is 0.06-0.08 MPa.
In the preparation method, in the step (5), the air inlet temperature during spray drying is 170-180 ℃, and the air outlet temperature is 75-85 ℃.
A preparation containing the traditional Chinese medicine composition for treating insomnia caused by liver depression and spleen deficiency is provided.
Wherein the preparation is powder and comprises 498 to 682 parts by weight of spray dry powder and 1000 parts by weight of dextrin.
Wherein the preparation is granules, the spray dry powder and the dextrin are uniformly mixed and then are granulated by a dry method, and the granules with 10-50 meshes are collected.
The composition of the invention is used by the following methods: 10g each time, 3 times daily.
Function and indication: soothe the liver, strengthen the spleen, clear heart and nourish heart. Can be used for treating insomnia with syndrome of liver stagnation and spleen deficiency, manifested by insomnia, vexation, irritability, abnormal stool and urine, red tongue tip, yellow and greasy fetus, and superficial and wiry pulse.
The invention has the beneficial effects that: the invention is suitable for dialectical treatment of liver-stagnation and spleen-deficiency type insomnia, and has remarkable curative effect and no obvious side effect.
Drawings
Fig. 1 is a water absorption curve chart of the decoction pieces.
Fig. 2 is a process flow diagram of the formulation.
Detailed Description
The technical solutions of the present invention will be described clearly and completely below, and it should be apparent that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be obtained by a person skilled in the art without making any creative effort based on the embodiments in the present invention, belong to the protection scope of the present invention.
1. Square solution of the invention
Monarch drug: the bupleurum root, radix bupleuri, bitter in taste and mild in nature, enters liver, gallbladder and lung channels, soothes liver and relieves depression, it is used as monarch drug to regulate liver qi. "Changsha Yao Jie" (Changsha Yao Jie) is a medicine for clearing away the fire in gallbladder meridian and disturbing heat in heart and home.
Ministerial drugs: (1) Chinese angelica root, radix Angelicae sinensis, sweet, pungent, bitter and warm in taste, nourishes blood and harmonizes blood: white peony root, radix Paeoniae alba and bupleuri radix, radix Paeoniae alba and bupleuri radix, all can nourish liver to help liver, make blood and liver harmonize, blood replenishes liver to soften, and enrich blood and check soul to help sleep: (2) The mint is light cooling powder, can sooth liver and relieve depression, the turmeric root-tuber is bitter and cold, and can clear heart and relieve depression: the cortex albiziae is sweet and neutral and enters heart and liver channels, can calm nerves and relieve depression, and the three medicines are used together to help the radix bupleuri to relieve liver depression: (3) The rhizoma pinelliae and the ginger are pungent and warm and disperse, can help the radix bupleuri to dissipate stagnation, can lower qi flowing down the stomach and can warm and resolve phlegm-dampness. The medicines are all monarch medicines.
Adjuvant drugs: gardenia jasminoides ellis relieves fire of triple energizer, rhizoma anemarrhenae clears fire of triple energizer deficiency and excess, forsythia is good at clearing heart fire, and the three medicines are used together to clear heat of heart and liver caused by stagnation of liver qi so as to treat insomnia caused by disquieted spirit; the spina date seed is sour and sweet in nature, can nourish heart and benefit liver, and the semen boitae can nourish yin and blood and communicate heart and kidney, so that the effect of nourishing heart and soothing nerves can be achieved directly by combining the two medicines. Are used as adjuvant drugs.
A messenger drug: prepared licorice root, radix Glycyrrhizae Praeparata, as a guiding drug, has the effects of tonifying qi, strengthening the middle-jiao, relieving the liver-fire, and harmonizing the effects of the other drugs in the recipe.
2. Single medicine
Bupleurum root: zhangyan et al found 23428that saikoside could significantly suppress the activities of rat hippocampal Acetylcholinesterase (AChE) and choline acetyltransferase (ChAT), and reduce the death of hippocampal nerve cells, which indicates that saikoside could regulate cholinergic nervous system to inhibit the activation of hypothalamus-pituitary-adrenal axis, and reduce the level of Cortisol (Cortisol); or reducing cholinergic nervous system activity, and increasing 5-hydroxytryptamine (5-HT) hormone level to achieve antidepressant effect. Related pharmacological researches find that the saikosaponin d can improve the activity of superoxide dismutase (SOD) in liver tissues of liver fibrosis rats, reduce the contents of IV type collagen (IV-C), laminin (LN) and Hyaluronic Acid (HA) in hematochezia, reduce the levels of aspartate Aminotransferase (AST) and glutamate-pyruvate transaminase (ALT) in hematochezia, and reduce the contents of Malondialdehyde (MDA) in liver tissues and blood serum, so that the saikosaponin d (SSd) HAs the effects of resisting hepatic fibrosis, protecting liver cells and the like.
Chinese angelica root: the polysaccharide in the angelica can stimulate bone marrow macrophages and mononuclear cells in hematopoietic induction niche, promote the synthesis and secretion of hematopoietic regulatory factors, thereby promoting the proliferation and differentiation of hematopoietic related cells such as granulo-monosystem hematopoietic progenitor cells, myeloid pleiotropic hematopoietic progenitor cells and the like, and promoting hematopoiesis.
White peony root: liweiqi et al found that paeoniflorin can exert antidepressant effect by regulating the expression of glutamic acid and its receptor in hippocampal tissue. Researches on the Li Yao and the like show that the white paeony root extract can obviously improve the oxidation resistance of liver and serum, thereby inhibiting liver injury and various inflammatory reactions caused by oxidative stress.
Mint: the study shows that a certain amount of herba Menthae or oleum Menthae Dementholatum can stimulate central nervous system, and has effects of inducing perspiration, relieving fever, tranquilizing mind and relieving pain. In addition, the mentha rotundifolia essential oil and the mentha piperita essential oil can obviously prolong the sleep time induced by the pentobarbital sodium, can relieve mental fatigue symptoms, has the function of resisting mental fatigue, and is characterized in that the content of amino acid neurotransmitters in brain regions related to mental fatigue can be regulated and controlled by using olfaction. The menthol can block the internal flow of sodium ions, thereby generating local nerve block and playing the role of analgesia.
Turmeric root-tuber: clinical observation and animal experiments show that the curcuma wenyujin volatile oil can reduce S-GDT activity, has certain repairing effect on liver function, and can correct A/G ratio inversion caused by hepatitis; meanwhile, the liver cell can be protected, and the liver tissue regeneration can be promoted.
Silktree albizzia bark: the inventor finds that the n-butyl alcohol extraction part plays an anxiolytic role by improving the GABA content in the mouse brain and reducing the Glu and 5-HT content in the mouse brain. Liaoying et al found that the cortex Albizziae extract can shorten the accumulated immobility time of mouse tail suspension test and forced swim ice test, and can resist the body temperature drop and eyelid ptosis of mice caused by reserpine, which fully indicates that the cortex Albizziae extract has antidepressant effect.
Tuckahoe, poria cocos: research shows that the diuretic action mechanism of tuckahoe is related to the potential antagonism of aldosterone receptor activity of tuckahoe, and tuckahoe exerts on total ATP enzyme and Na in cells + -K + -ATPase has a certain degreeHas activating effect, and can promote water and salt metabolism and improve myocardial motion. The pachymanol can reduce transaminase activity, prevent hepatocyte necrosis, and protect liver injury of carbon tetrachloride-induced liver cirrhosis model rat.
White atractylodes rhizome: plum established an acetaminophen-induced mouse acute liver injury model, and studied the effect and mechanism of bighead atractylodes rhizome volatile oil on mouse acute liver injury. The experimental results show that: the mice with acute liver injury are pretreated by the bighead atractylodes rhizome volatile oil, so that the ALT and AST levels in blood of the mice with liver injury can be reduced, and the GSH level in livers can be increased.
Pinellia ternata: it is discovered by Tangying and the like that pinellia ternate alkaloids have an effect of improving learning and memory disorders of aging model mice caused by D-galactose, can obviously improve SOD activity in brain tissues of the mice, obviously reduce Malondialdehyde (MDA) content, and can obviously reduce acetylcholinesterase (AChE) content at medium and high doses, and are presumed to be related to antioxidation of the pinellia ternate alkaloids and inhibition of acetylcholinesterase activity.
Ginger: experimental research shows that the ginger ethanol extract can obviously improve the blood fat quality of experimental rabbits and reduce the change of atherosclerosis. The ginger alcohol extract can also obviously inhibit platelet aggregation induced by adenosine diphosphate and delay blood coagulation. The ginger extract can prevent lipoprotein from immersing in the arterial wall, improve the vascular structure, regulate the conversion of cholesterol, promote the transport function of high-density lipoprotein and promote the function of gallbladder to excrete cholesterol, and is an atherosclerosis inhibitor with development prospect.
Gardenia: in a mouse model of carbon tetrachloride-induced hepatotoxicity, geniposide can reduce the activities of blood glutamate aminotransferase and aspartate aminotransferase and increase the concentration of Glutathione (GSH) in the liver, thereby playing a role in protecting the liver.
Rhizoma anemarrhenae: saponin of rhizome of Anemarrhena asphodeloides has effects of significantly reducing oxygen consumption rate increase caused by thyroxine and inhibiting activity of Na (+) K (+) -ATP acid, wherein the total saponin has inhibition rate of 59.8% on Na (+) K (+) -ATP enzyme and inhibition rate of 89.8% on hemisuccinate derivative, and is considered to be related to effects of clearing heat and purging fire.
Fructus forsythiae: experiments for studying the liver protection effect of the forsythia suspense aqueous extract on mice through a hyperlipidemia model show that the serum of the hyperlipidemia mice has higher levels of Total Cholesterol (TC), triacylglycerol (TG) and low-density lipoprotein (LDL) compared with the normal mice, and the level of high-density lipoprotein (HDL) compared with the normal mice is lower. The oral fructus forsythiae aqueous extract of the hyperlipidemic mouse can reduce the content of TC, TG and LDL in serum and increase the content of HDL; in addition, fructus forsythiae water extract also reduces liver Malondialdehyde (MDA) content, improves superoxide dismutase (SOD) activity, and regulates serum Total Bilirubin (TBIL) metabolism, thereby achieving liver protecting effect.
Wild jujube seed: the julep and the like prove that the spina date seed total alkaloids have a certain depression resistance effect on mice by adopting a mouse tail suspension experiment, an empty field experiment and an experiment for reducing the body temperature caused by antagonizing reserpine. Sunlizhi et al observed that the spina date seed decoction can obviously improve the behaviouristics of chronic depressed rats, and the mechanism of the spina date seed decoction is possibly related to the expression level of regulatory protein. Zuojun et al have proved the mechanism of antidepressant action of jujuba seeds through the research on the influence of jujuba seeds on monoamine neurotransmitters, inflammatory cytokines and neurotrophic factors. The results of Wang Gekko Swinhonis and the like which adopt an international general anxiety animal model, namely an elevated plus maze model, show that polysaccharide and flavonoid components in the spina date seed aqueous solution extract are probably material bases with the effect of resisting anxiety.
Seed of Chinese arborvitae: the effects of tranquilizing, hypnotizing and resisting anoxia of the total terpene components in the platycladi seeds are researched by maoxin and the like. The total terpene components can inhibit the spontaneous activity of mice, prolong the sleep time of the mice induced by pentobarbital sodium, increase the sleep number of the mice and prolong the survival time of anoxic mice.
Honey-fried licorice root: a large number of documents show that liquorice and honey-fried licorice root exist in most anti-depression traditional Chinese medicine prescriptions, wherein the bupleurum liver-soothing powder (white paeony root, bupleurum, liquorice, dried orange peel, ligusticum wallichii and rhizoma cyperi) can improve hippocampal neurons by regulating and controlling hippocampal dendrite and synapse morphology so as to achieve the anti-depression effect. The spina date seed decoction is used for intervening the development of depression by influencing inflammatory cytokines and monoamine neurotransmitters.
3. Formulation examples
Formulation example 1
A traditional Chinese medicine composition for treating liver depression and spleen deficiency type insomnia comprises 225g of radix bupleuri, 150g of Chinese angelica, 150g of radix paeoniae alba, 125g of mint, 150g of radix curcumae, 250g of cortex albiziae, 300g of poria cocos, 225g of rhizoma atractylodis macrocephalae, 225g of rhizoma pinellinae praeparata, 150g of ginger, 150g of fructus gardeniae, 150g of rhizoma anemarrhenae, 150g of fructus forsythiae, 300g of spina date seed, 250g of semen boitae and 125g of honey-fried licorice root.
Formulation example 2
The difference from the example 1 is that the composition comprises the following components in parts by weight: 200g of radix bupleuri, 125g of angelica, 125g of radix paeoniae alba, 100g of mint, 125g of radix curcumae, 225g of cortex albiziae, 275g of poria cocos, 200g of rhizoma atractylodis macrocephalae, 200g of rhizoma pinellinae praeparata, 125g of ginger, 125g of fructus gardeniae, 125g of rhizoma anemarrhenae, 125g of fructus forsythiae, 275g of spina date seed, 225g of semen boitae and 100g of honey-fried licorice root.
Formulation example 3
The adhesive is the same as the adhesive in example 1, except that the adhesive comprises the following components in parts by weight: 250g of radix bupleuri, 175g of angelica sinensis, 175g of radix paeoniae alba, 150g of mint, 175g of radix curcumae, 275g of cortex albiziae, 325g of poria cocos, 250g of rhizoma atractylodis macrocephalae, 250g of rhizoma pinellinae praeparata, 175g of ginger, 175g of fructus gardeniae, 175g of rhizoma anemarrhenae, 175g of fructus forsythiae, 325g of spina date seed, 275g of semen boitae and 150g of honey-fried licorice root.
4. Extraction process
4.1 immersion time of decoction pieces, water absorption
Weighing 9g of radix bupleuri, 6g of angelica sinensis, 6g of radix paeoniae alba, 5g of mint, 6g of radix curcumae, 10g of cortex albiziae, 12g of poria cocos, 9g of rhizoma atractylodis macrocephalae, 9g of rhizoma pinellinae praeparata, 6g of ginger, 6g of fructus gardeniae, 6g of rhizoma anemarrhenae, 6g of fructus forsythiae, 12g of spina date seeds, 10g of semen boitae and 5g of radix glycyrrhizae preparata according to the formula proportion (formula example 1), putting the weighed materials into a 3L beaker, adding 10 times of water, filtering out unabsorbed water at 0min, 10min, 20min, 30min, 50min and 90min respectively, weighing the medicine residues, calculating the water absorption rate (table 1), and drawing a water absorption dynamic change graph (see fig. 1).
TABLE 1 study of water absorption of decoction pieces
Time t/ |
0 | 10 | 20 | 30 | 50 | 90 |
Water absorption/%) | 0 | 63.39 | 93.72 | 110.82 | 116.76 | 121.93 |
As can be seen from table 1 and fig. 1: the water absorption rate is high after 0-30 min, and after 30min, the water absorption rate tends to be gentle, so the soaking time can reach balance after 30min, and as the heating and boiling process of large-scale production is generally more than 30min, the soaking time is selected to be 30min during small-scale examination, and the soaking is not selected during large-scale production.
Weighing 9g of radix bupleuri, 6g of angelica sinensis, 6g of radix paeoniae alba, 5g of mint, 6g of radix curcumae, 10g of cortex albiziae, 12g of poria cocos, 9g of rhizoma atractylodis macrocephalae, 9g of rhizoma pinellinae praeparata, 6g of ginger, 6g of fructus gardeniae, 6g of rhizoma anemarrhenae, 6g of fructus forsythiae, 12g of spina date seeds, 10g of semen boitae and 5g of radix glycyrrhizae preparata according to the formula proportion (formula example 1), weighing 3 parts of 123g of each part, putting the 3L beaker into a beaker, adding 10 times of water, soaking for 30 minutes, stirring once every 10 minutes, filtering out unabsorbed water, weighing dregs of a decoction, and calculating (see table 2).
Water absorption (%) = (wet weight of herb residue-dry weight of herb material)/dry weight of herb material)% 100%
TABLE 2 dynamic Water uptake test mean values
The results show that the water absorption rates of the three decoction pieces after 30 minutes soaking are 113.41%, 114.71% and 111.63%, respectively, and the average water absorption rate is 113.25%.
4.2 investigation of different water addition times
4.2.1 addition of Water
Weighing 45g of radix bupleuri, 30g of Chinese angelica, 30g of white paeony root, 25g of mint, 30g of radix curcumae, 50g of cortex albiziae, 60g of poria cocos, 45g of bighead atractylodes rhizome, 45g of rhizoma pinellinae praeparata, 30g of ginger, 30g of cape jasmine fruit, 30g of rhizoma anemarrhenae, 30g of fructus forsythiae, 60g of spina date seed, 50g of platycladi seed and 25g of honey-fried licorice root according to the formula proportion (formula example 1), weighing 3 parts, respectively placing the 3 parts in a round-bottomed flask, connecting a reflux device, adding water for decocting twice for fifteen medicines (except the mint), adding water with the amount of 6, 8 and 10 times of the prepared slices for the first time, soaking for 30 minutes, adding the mint after extracting for 105 minutes, extracting for 15 minutes, and filtering the decoction for later use by a 200-mesh screen; adding water in an amount which is 6, 8 and 10 times that of the decoction pieces for the second time, extracting for 90 minutes, filtering decoction liquid by a 200-mesh screen, and combining the filtrates.
4.2.2 determination of cream yield
Decocting and extracting according to the conditions, combining the decoctions extracted twice, decompressing and concentrating the decoction, and fixing the volume to 5000mL. Precisely transferring 25mL of the extract into an evaporation dish dried to constant weight, evaporating the extract in a water bath, drying the extract in an oven at 105 ℃ for 3 hours, placing the dried extract in a dryer for cooling for 30 minutes, rapidly and precisely weighing the extract, calculating the paste yield, and parallelly measuring two parts in each group, wherein the results are shown in Table 3.
TABLE 3 cream yield for different water addition times
General water addition times | Multiple of water addition for two-decoction | Percentage of cream discharged (%) |
6 | 6 | 19.1 |
8 | 8 | 20.3 |
10 | 10 | 20.6 |
The data in table 3 show that when the water addition amount is 6 times, 8 times and 10 times, the paste yield is 19.1%, 20.3% and 20.6% respectively, the difference is small, and according to the actual large-scale production and the water resource saving, the final selection is to add 6 times of water for the first time and 6 times of water for the second time.
4.3 different extraction time review
4.3.1 extraction time
Weighing 45g of radix bupleuri, 30g of Chinese angelica, 30g of white paeony root, 25g of mint, 30g of radix curcumae, 50g of cortex albiziae, 60g of poria cocos, 45g of bighead atractylodes rhizome, 45g of rhizoma pinellinae praeparata, 30g of ginger, 30g of cape jasmine, 30g of rhizoma anemarrhenae, 30g of fructus forsythiae, 60g of spina date seed, 50g of platycladi seed and 25g of honey-fried licorice root according to the proportion of a formula (formula embodiment 1), weighing 3 parts, respectively placing the 3 parts in a round-bottom flask, connecting a reflux device, adding water into the fifteen medicines (except the mint), decocting the medicines twice, adding water in an amount which is 6 times that of the prepared medicines into the first time, soaking the medicines for 30 minutes, respectively extracting the medicines for 150 minutes, 120 minutes and 90 minutes, respectively adding the mint 15 minutes before the extraction is finished, and filtering the decoction by a 200-mesh screen for later use; adding water 6 times the amount of the decoction pieces for the second time, extracting for 120, 90, and 60 minutes respectively, filtering the decoction with 200 mesh sieve, and mixing the filtrates.
4.3.2 determination of cream yield
Decocting and extracting according to the conditions, mixing decoctions extracted twice, decompressing and concentrating the decoctions, and fixing the volume to 5000mL. Precisely transferring 25mL of the extract into an evaporation dish dried to constant weight, evaporating the extract in a water bath, drying the extract in an oven at 105 ℃ for 3 hours, placing the dried extract in a dryer for cooling for 30 minutes, rapidly and precisely weighing the extract, calculating the paste yield, and parallelly measuring two parts in each group, wherein the results are shown in Table 4.
TABLE 4 cream yield at different extraction times
One time frying (min) | Two decocting time (min) | Percentage of cream discharged (%) |
150 | 120 | 20.0 |
120 | 90 | 19.1 |
90 | 60 | 18.9 |
The data in table 4 show that the extraction rates of the paste are 20.0%, 19.1% and 18.9% respectively under 3 different extraction times, the difference is not great, and one decoction for 120 minutes and two decoctions for 90 minutes are selected as the extraction times in combination with the actual situation of mass production.
4.4 investigation of separation Process
4.4.1 separation Process
Weighing 45g of radix bupleuri, 30g of Chinese angelica, 30g of white paeony root, 25g of mint, 30g of radix curcumae, 50g of cortex albiziae, 60g of poria cocos, 45g of bighead atractylodes rhizome, 45g of rhizoma pinellinae praeparata, 30g of ginger, 30g of cape jasmine fruit, 30g of rhizoma anemarrhenae, 30g of fructus forsythiae, 60g of spina date seed, 50g of platycladi seed and 25g of honey-fried licorice root according to the proportion of a formula (formula embodiment 1), weighing 3 parts, respectively placing the 3 parts in a round-bottomed flask, connecting a reflux device, adding water to decoct the fifteen medicines (except the mint), adding water for twice, adding water with the amount 6 times of the amount of the prepared slices for the first time, soaking for 30 minutes, adding the mint after extracting for 105 minutes, and extracting for 15 minutes; adding water 6 times the amount of the decoction pieces for the second time, extracting for 90min, performing solid-liquid separation with 100, 200, and 300 mesh sieves, respectively, and mixing the two decoctions.
4.4.2 determination of cream yield
Decocting and extracting according to the conditions, mixing decoctions extracted twice, decompressing and concentrating the decoctions, and fixing the volume to 5000mL. Precisely transferring 25mL of the extract into an evaporation dish dried to constant weight, evaporating the extract by a water bath, drying the extract in an oven at 105 ℃ for 3h, placing the dried extract in a dryer for cooling for 30min, rapidly and precisely weighing the extract, calculating the paste yield, and parallelly measuring two parts in each group. The results are shown in Table 5.
TABLE 5 cream yield at different extraction times
The data in table 5 show that the extraction rate of the extract is 19.6%, 19.1% and 17.5% respectively by using 100 mesh, 200 mesh and 300 mesh screens, the clarity of the filtrate is not high by using 100 mesh filtration, but 300 mesh filtration is adopted, the filtration time is longer, and the 200 mesh screen is selected for filtration during solid-liquid separation in combination with the actual situation of large-scale production.
4.5 drying Process
4.5.1 selection of drying means
The common drying methods of the traditional Chinese medicine extract mainly comprise vacuum oven drying and spray drying. Vacuum oven drying still has certain drawbacks and limitations. The vacuum oven has long drying time, high energy consumption and easy contamination and moisture absorption in intermittent operation. The spray drying method has the characteristics of high drying speed, short material heating time, simple production process, simple and convenient operation, good controllability, uniform product texture, good dissolubility and the like. Therefore, the product is spray-dried.
4.5.2 spray drying test
Weighing 135g of radix bupleuri, 90g of Chinese angelica, 90g of white paeony root, 75g of mint, 90g of radix curcumae, 150g of cortex albiziae, 180g of poria cocos, 135g of bighead atractylodes rhizome, 135g of rhizoma pinellinae praeparata, 90g of ginger, 90g of cape jasmine fruit, 90g of rhizoma anemarrhenae, 90g of fructus forsythiae, 180g of spina date seed, 150g of platycladi seed and 75g of honey-fried licorice root according to the formula proportion (formula embodiment 1), extracting by using a multifunctional extraction and concentration tank, adding 6 times of water into the fifteen medicines (except the mint), adding the mint after extracting for 105 minutes, extracting for 15 minutes again, and filtering a 200-mesh decoction solution for later use; adding 6 times of water into the decoction pieces for the second time, extracting for 90 minutes, filtering the decoction through a 200-mesh screen, and combining the filtrates. Concentrating the filtrate, fixing the volume to 3000ml, precisely transferring 25ml into an evaporating dish dried to constant weight, evaporating in a water bath, drying in an oven at 105 ℃ for 3h, cooling in a dryer for 30min, rapidly and precisely weighing, and calculating the cream yield to obtain the theoretical cream yield of 17.8%. According to the optimal working conditions and material properties of the spray drying equipment, the air inlet temperature is set to be 180 ℃, the spraying is carried out under the condition that the air outlet temperature is 80 ℃, the spray powder does not have the wall sticking phenomenon, loose spray powder can be collected, the spraying effect is good, and the selected spray drying process is feasible.
4.6 granulation Process Studies
4.6.1 granulation Process
The common granulation modes of the granules comprise wet granulation and dry granulation, the wet granulation process is complex, materials are mixed with proper auxiliary materials and then added with adhesive to prepare soft materials, and the soft materials are granulated by a granulator and then dried, so the production period is long; the dry granulation adopts a granulation method that a screw feeder extrudes dry powdery materials into slices through a pressing wheel, and then the slices are crushed into dry particles with proper sizes.
After dry granulation, collecting granules of 10-50 meshes as a finished product of the final granules.
4.6.2 examination of the amount of auxiliary materials
The spray powder is taken, dextrin with different proportions is added, dry granulation is adopted, the influence of the dextrin dosage on the granulation is inspected, the result shows that the auxiliary materials have no influence on the granule yield, the granule dissolubility also accords with the regulation, and the effect of the dry granulation and the granule dissolubility are not influenced by adding the auxiliary materials. The results are shown in Table 6.
TABLE 6 Effect of adjuvant dosage on granulation
Amount of spray powder (g) | Paste precision (g) | Particle yield (%) | Solubility in water | Situation of granulation |
300 | 0(%) | 91.1 | Qualified | Good compressibility and uniform particle size |
270 | 30(10%) | 91.3 | Qualified | Good compressibility and uniform particle |
225 | 75(25%) | 91.7 | Qualified | Good compressibility and uniform particle |
150 | 150(50%) | 91.8 | Qualified | Good compressibility and uniform particle size |
4.7 pilot study
4.7.1 extraction
Weighing 135g of radix bupleuri, 90g of Chinese angelica, 90g of white paeony root, 75g of mint, 90g of radix curcumae, 150g of cortex albiziae, 180g of poria cocos, 135g of bighead atractylodes rhizome, 135g of rhizoma pinellinae praeparata, 90g of ginger, 90g of cape jasmine fruit, 90g of rhizoma anemarrhenae, 90g of fructus forsythiae, 180g of spina date seed, 150g of platycladi seed and 75g of honey-fried licorice root according to the formula proportion (formula embodiment 1), weighing three parts, respectively using a multifunctional extraction and concentration tank to extract the fifteen medicines (except the mint), adding water for decoction twice, adding water with the amount being 6 times of that of the decoction pieces for the first time, soaking for 30 minutes, adding the mint after extracting for 105 minutes, extracting for 15 minutes again, and filtering decoction for later use; adding water with the amount 6 times of the decoction pieces for the second time, extracting for 90 minutes, filtering decoction, and mixing filtrates.
4.7.2 concentration, drying
The decoction is decompressed and concentrated to an extract with the relative density of 1.05-1.15 (60 ℃). And (3) taking the extract, spray-drying, controlling the air inlet temperature to be 170-180 ℃ and the air outlet temperature to be 75-85 ℃, collecting spray powder, weighing, and calculating the cream yield, wherein the cream yield is shown in table 7.
TABLE 7 cream yield of three lots of small trials
Batch number | Amount of spray powder (g) | Percentage of cream discharged (%) |
202103011 | 319.2 | 17.3 |
202103012 | 324.7 | 17.6 |
202103013 | 328.4 | 17.8 |
The data in Table 7 show that the cream yield of the three batches of small tests is 17.3%, 17.6% and 17.8%, respectively, and the differences are not great. Test results show that the spray drying is carried out by adopting the process parameters, the yield of the spray powder is relatively stable, and no wall sticking phenomenon exists in the spraying process, so that the spray drying conditions are determined as follows: 170-180 ℃ and the air outlet temperature is 75-85 ℃.
4.7.3 Dry granulation
According to the optimal working conditions and material properties of dry granulation equipment, setting dry granulation conditions, taking spray powder, adding a proper amount of dextrin, uniformly mixing, performing dry granulation, and collecting 10-50-mesh granules. The results are shown in Table 8.
Table 8 small test granulation results
Batch number | Amount of spray powder (g) | Paste quantity (g) | Gross combined weight (g) | Amount of particles (g) | Particle yield (%) |
202103011 | 319.2 | 280.8 | 600 | 550.4 | 91.7 |
202103012 | 324.7 | 275.3 | 600 | 549.4 | 91.6 |
202103013 | 328.4 | 271.6 | 600 | 547.6 | 61.3 |
The test results show that the parameters and the particle yield of each link are stable, and the dry granulation process is feasible.
4.8 summary of the technology
According to the production capacity of production equipment, feeding according to the prescription amount, preparing three batches of products according to the determined production process, and verifying the feasibility of the production process.
4.8.1 formulation
1350g of radix bupleuri, 900g of angelica, 900g of radix paeoniae alba, 750g of mint, 900g of radix curcumae, 1500g of cortex albiziae, 1800g of poria cocos, 1350g of rhizoma atractylodis macrocephalae, 1350g of rhizoma pinellinae praeparata, 900g of ginger, 900g of fructus gardeniae, 900g of rhizoma anemarrhenae, 900g of fructus forsythiae, 1800g of spina date seed, 1500g of semen boitae and 750g of honey-fried licorice root.
4.8.2 pretreatment of decoction pieces
Bupleurum root: removing impurities and residual stem, cleaning, moistening, slicing, and drying.
Chinese angelica: removing impurities, cleaning, moistening, slicing, and drying at low temperature.
White peony root: cleaning, moistening, slicing, and drying.
Mint: removing old stems and impurities, slightly spraying clear water, slightly moistening, cutting into short segments, and drying at low temperature in time.
Turmeric root-tuber: cleaning, moistening, slicing, and drying.
Silktree albizzia bark: removing impurities, cleaning, moistening, shredding, and drying.
Poria cocos: soaking Poria, cleaning, moistening, steaming, removing outer skin, cutting into blocks or thick pieces, and sun drying.
White atractylodes rhizome: removing impurities, cleaning, moistening, slicing, and drying.
Rhizoma pinelliae preparata: taking pinellia ternata, separating the pinellia ternata into different sizes, soaking the pinellia ternata in water until no dry core exists in the pinellia ternata, and taking out the pinellia ternata; and decocting a proper amount of liquorice in water twice, mixing decoction, pouring into lime liquor prepared from a proper amount of water, uniformly stirring, adding the soaked pinellia ternata, soaking, stirring for 1-2 times every day, keeping the pH value of the soaking solution above 12 until the section is yellow and uniform, taking out when the mouth tastes slightly numb and tongue, cleaning, and drying in the shade or drying to obtain the rhizoma pinelliae beverage.
Ginger: removing impurities, and cleaning. It is available in the form of thick slices.
Gardenia: removing impurities, and grinding.
Rhizoma anemarrhenae: removing impurities, cleaning, moistening, slicing, drying, and removing hair and dandruff.
Fructus forsythiae: and removing impurities.
Wild jujube seed: the residual core shell was removed. Pounding into pieces for use.
Arborvitae seed: removing impurities and residual seed coats.
Honey-fried licorice root: parching Glycyrrhrizae radix tablet with honey until it is yellow to dark yellow, taking out when it is not sticky, and cooling.
4.8.3 preparation technology (fig. 2)
(1) Weighing the medicinal materials according to the weight ratio;
(2) Decocting bupleuri radix, radix Angelicae sinensis, radix Paeoniae alba, radix Curcumae, cortex Albizziae, poria, atractylodis rhizoma, rhizoma Pinelliae Preparata, rhizoma Zingiberis recens, fructus Gardeniae, rhizoma anemarrhenae, fructus forsythiae, semen Ziziphi Spinosae, semen Platycladi and radix Glycyrrhizae Preparata with 6 times of water, extracting for 105 min, adding herba Menthae, extracting for 15 min, and filtering (200 mesh screen);
(3) Adding 6 times of water into the solid filtered in the step (2) for decocting, extracting for 90 minutes, and filtering (200-mesh screen);
(4) Combining the filtrates in the step (2) and the step (3), and concentrating under reduced pressure at a vacuum degree of 0.06-0.08 MPa to obtain clear paste with a relative density (60 ℃) of 1.05-1.16;
(5) And spray drying the clear paste, wherein the air inlet temperature is 170-180 ℃, the air outlet temperature is 75-85 ℃, and spray dry powder is obtained.
(6) Collecting spray powder, adding a proper amount of dextrin, uniformly mixing, performing dry granulation (the conveying speed is less than or equal to 220rpm, the working pressure is 12-25 MPa), granulating, collecting 10-50-mesh granules, and subpackaging 10g of granules in each bag.
Table 9 Process verification results
Batch number | 210601 | 210602 | 210603 |
Extracting and feeding amount (kg) | 6.15 | 6.15 | 6.15 |
Amount of spray powder (kg) | 1.21 | 1.19 | 1.14 |
Extraction yield (%) | 19.7 | 19.3 | 18.5 |
Dextrin amount (kg) | 0.79 | 0.81 | 0.86 |
Gross combined weight (kg) | 2.0 | 2.0 | 2.0 |
Amount of particles (kg) | 1.86 | 1.88 | 1.90 |
Theoretical quantity of finished product (bag) | 200 | 200 | 200 |
Finished product quantity (bag) | 183 | 186 | 187 |
Yield of finished products | 91.5 | 93.0 | 93.5 |
The samples of each batch were examined according to the relevant regulations under 0104 granules, 2020 edition of the four ministry of communications in Chinese pharmacopoeia, and the data of the examination are shown in Table 10.
Table 10 process verification test results
The results show that the average cream yield of the three batches of samples is 19.2%, the cream yield is stable, and all detection indexes meet the regulations, which indicates that the production process is stable and feasible.
5. Stability test
According to the guiding principle of stability test of medicines and preparations of four parts 9001 in the 2020 edition of Chinese pharmacopoeia, samples for stability research are divided into 3 batches with the batch numbers of 210601, 210602 and 210603, and the used packages are medicinal aluminum-plastic composite films.
5.1 accelerated test
Taking 3 batches of test articles, placing and observing for 6 months under the conditions of 40 +/-2 ℃ and 75 +/-5% of relative humidity, and sampling and detecting for 0, 1, 2, 3 and 6 months respectively. The results are shown in tables 11 to 13.
TABLE 11 test results of accelerated test on test article lot 210601
Table 12 test sample accelerative test investigation results of lot number 210602
Table 13 test sample Accelerator test investigation results of batch number 210603
5.2 Long term test
Taking 3 batches of test articles, placing and observing for 24 months under the conditions that the temperature is 25 +/-2 ℃ and the relative humidity is 60 +/-5%, and sampling and detecting for 0, 3, 6, 9, 12, 18 and 24 months respectively. The results are shown in tables 14 to 16.
Table 14 test results of Long-term test on test article lot 210601
Table 15 test results of Long term test on test article lot 210602
TABLE 16 Long-term test examination of test article under batch No. 210603
5.3 results of the experiment
The experiment is intended to carry out an accelerated test of 6 months and a long-term test of 24 months, the current accelerated test finishes the detection of 6 months, the long-term test finishes the detection of 12 months, and all the investigation items are within the range specified by the quality standard, which indicates that the quality of the particles prepared by the process of the invention is stable.
6. Treatment cases
The traditional Chinese medicine formula has been used clinically for many years, has a good treatment effect on insomnia with liver depression and spleen deficiency, and only a part of specific cases are listed below for explanation due to a plurality of cases of successful treatment.
Case 1 a certain, male, age 67.
The patient had difficulty falling asleep for 2 years. In the last 2 years, patients have difficulty in falling asleep, are easy to wake up after sleeping, are irritative, dreamful, have palpitation and forgetfulness, have poor spirit and fatigue and poor appetite, and are accompanied by light headedness, lusterless complexion, lassitude of limbs, abdominal distension and loose stool; a pale tongue with thin coating and a thready and weak pulse. Has no history of hypertension, diabetes, coronary heart disease, etc. Once the diazepam tablets are orally taken at 2.5mg and 1 night, the diazepam tablets are gradually added until the diazepam tablets are orally taken at 5mg and 1 night, so that drug dependence gradually appears, and a patient asks for traditional Chinese medicine conditioning treatment. Initial diagnosis in 8 months and 16 days in 2017. Traditional Chinese medicine diagnosis: insomnia, liver stagnation and spleen deficiency.
After the patient takes the medicine (formula example 1) for 1 week, the symptoms are improved, dreaminess does not exist, fatigue and weakness are improved, excrement is normal, abdominal distension does not exist, and sleep is improved. After the medicine is continuously taken by the original formula, the symptoms are obviously improved after 7 times of taking the medicine, and the disease is recuperated with the symptoms and does not relapse.
Case 2 somebody, female, age 56.
Insomnia was observed for 3 years. The patients have insomnia in the last 3 years, are easy to wake up after sleeping, are sleepless after waking up, are dreaminess, are tired and lack of strength, have poor appetite, are tired in limbs, are dizziness, palpitation, short breath, sigh, loose stool and frequent night urination; dark tongue with thin coating and wiry, thready and weak pulse; first diagnosis in 2021 year 3, month 25. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency.
After the medicine is taken (formula example 1), the symptoms are improved after 7 doses, the original formula is continued to be taken, and the symptoms are obviously improved after 7 doses, and then the symptoms are conditioned along with the symptoms.
Case 3 Zhao somebody, female, 60 years old.
Insomnia was observed for 3 years. The patients have insomnia in the last 3 years, are easy to wake up after sleeping, are sleepless after waking up, are dreaminess, are tired and lack of strength, have poor appetite, are tired in limbs, are dizziness, palpitation, short breath, sigh, loose stool and frequent night urination; dark tongue with thin coating and wiry, thready and weak pulse; initial diagnosis in 12 months and 20 days in 2020. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency.
After the medicine is taken (formula example 1), the symptoms are improved after 7 doses, the original formula is continued to be taken, and the symptoms are obviously improved after 7 doses, and then the symptoms are conditioned along with the symptoms.
Case 4 jingzheng, female, 71 years old.
The patients complain about the difficulty of falling asleep for 3 years, and have the symptoms of insomnia after waking up, headache, amnesia, listlessness, irritability, dry and bitter mouth and unformed stool. Pale and swollen with teeth marks, dark tongue with yellow and greasy coating, and wiry and slippery pulse. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency.
After 7 doses (one dose per day) of the medicine (formula example 1), the patient can better sleep before sleeping, the sleep time is improved, and the patient does not have headache, hypodynamia, dry mouth, bitter taste and improved stool. After the original prescription is continuously taken for 7 days, the tongue is pale, the tongue coating is yellow, the pulse is wiry and smooth, the sleep is obviously improved, the headache is not caused, the fatigue is caused, the mouth is dry, the mouth is bitter, and the stool is improved to some extent. The composition is administered continuously to consolidate the treatment.
Case 5, a vigorous male, age 67.
The patient mainly complains about the difficulty in falling asleep for 2 years, easily arouses the patient after sleeping, is irritable, dreamful, has palpitation and amnesia, has mental fatigue and poor appetite, and is accompanied with dizziness, lusterless complexion, lassitude of limbs, abdominal distension and loose stool. Once orally administered diazepam tablets 2.5mg late 1, were gradually added to 5mg late 1 for oral administration. A pale tongue with thin coating and a thready and weak pulse. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency.
After 7 doses (one dose per day) of the medicine (formula example 1) are taken, the sleep is improved obviously, dreams do not exist, the mental fatigue and the fatigue are improved, the excrement is normal, and abdominal distension does not exist. After the original formula is continuously taken for 7 days, the symptoms are improved, dreaminess is avoided, the spirit fatigue and the fatigue are improved, the excrement is normal, abdominal distension is avoided, and the sleep is improved. The composition is administered continuously to consolidate the treatment.
Case 6, tanacetum parthenium, female, age 53.
Complaining about difficulty in falling asleep for 3 years, dreaminess, insomnia all night, irritability, dizziness, fullness of head, conjunctival congestion, tinnitus, dry and bitter mouth, poor appetite, constipation, and dark urine. Once orally administered diazepam tablets 2.5mg late 1, were gradually added to 5mg late 1 for oral administration. A red tongue with yellow coating and a wiry and rapid pulse. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency, and liver fire disturbing the heart.
After 7 doses (one dose per day) of the medicine (formula example 1), all symptoms are relieved, the sleep can reach 4 to 6 hours, the mouth is still dry, and the stool is normal. After the original formula is continuously taken for 7 days, the sleep is obviously improved before the original formula is taken, and the stool is normal. The composition is administered continuously to consolidate the treatment.
Case 7 defends a bridge, female, age 54.
Complaining of difficulty in falling asleep for 5 years, easy to wake up, insomnia after waking up, dreaminess, insomnia throughout the night, irritability, dizziness, fullness in the head, conjunctival congestion, tinnitus, dry and bitter mouth, poor appetite, constipation, and dark urine. Right lung middle lower lobe resection. A red tongue with yellow coating and a wiry and rapid pulse. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency, and liver fire disturbing the heart.
After 7 doses (one dose per day) of the medicine (formula example 1), the symptoms are relieved, the sleep can reach 4 to 6 hours, the mouth is still dry, and the stool is normal. After the original formula is continuously taken for 7 days, the sleep is obviously improved before the original formula is taken, and the stool is normal. The composition is administered continuously to consolidate the treatment.
Case 8, lithe, female, age 49.
The chief complaints are half a year of difficulty in falling asleep, easy to wake up after sleeping, dreaminess, irritability, vexation, dry mouth and bitter taste, dysphoria with feverish sensation in the chest, dry throat and less body fluid, normal menstrual cycle, small dosage and dark blood. The history of hypertension is 6 years, the blood pressure is up to 180/120mmHg, and the levamlodipine besylate tablet is orally taken. The tongue is red with little coating and the pulse is thready and rapid. And (3) diagnosis: insomnia, liver stagnation, spleen deficiency, disharmony between heart and kidney.
After 7 doses (one dose per day) of the medicine (formula example 1), all symptoms are improved, and the medicine is small in dosage, dark in blood and lumpy in menstrual period; the tongue is red with little coating and the pulse is thready and rapid. After the original formula is continuously taken for 7 days, the sleep is obviously improved and the symptoms are improved. The composition is administered continuously to consolidate the treatment.
Case 9, swallow certain way, male, 60 years old.
Complaining of insomnia after waking up for 2 years. Poor sleep quality, easy waking after sleeping, insomnia after waking up, dreaminess, vexation, chest distress, epigastric fullness, nausea, belch, heavy head and blurred vision; the stool is normal. A reddish tongue with yellow and greasy coating and a slippery and rapid pulse. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency, and phlegm-heat disturbing the heart.
After 7 doses (one dose per day) of the medicine (formula example 1), all symptoms are improved, and the sleep is improved better. The stool is normal. The medicine is continuously taken in the front to consolidate the treatment.
Case 10 Liu somebody organ, female, 63 years old.
Complaining about the difficulty in falling asleep for 1 year. It often falls asleep after 1 o 'clock, and awakens about 4 o' clock, dreaminess, restlessness, irritability, palpitation, amnesia, mental fatigue, poor appetite, dizziness, lusterless complexion, lassitude of limbs, abdominal distension and loose stool. Left lung lobe carcinoma 3 years after surgery; the history of hypertension is 1 year. A pale tongue with thin coating and a thready and weak pulse. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency.
After 7 doses (one dose per day) of the medicine (formula example 1) are taken, all symptoms are improved, dreaminess, mental fatigue, fatigue and fatigue are improved, excrement is normal, abdominal distension is avoided, and sleep is improved. The composition is administered continuously to consolidate the treatment.
Case 11 cotton Wang, female, 63 years old.
Master complaints and easy waking for 2 years. Easy to wake up after sleeping, difficult to fall asleep after waking up, dreaminess, vexation, timidity, palpitation, easy to fright when touching, shortness of breath, spontaneous perspiration, lassitude and hypodynamia. Pale tongue and wiry and thready pulse. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency.
After 7 doses (one dose per day) of the medicine (formula example 1), all symptoms are improved, but the symptoms are listlessness, hypoappetite and limb lassitude. After the original formula is continuously taken for 7 days, all symptoms are obviously improved, and the sleep is obviously improved. The composition is administered continuously to consolidate the treatment.
Case 12, liaohua, female, 60 years old.
Complaining about difficulty falling asleep for 10 years. Easy waking after sleeping, difficult falling asleep after waking, dreaminess, gradual aggravation, even insomnia all night, irritability, dizziness and fullness, tinnitus, dry mouth and bitter taste, poor appetite, dry stool and frequent night urination; once orally taken, various sedatives have unsatisfactory effect, and can fall asleep when being taken and repeatedly after being stopped. A red tongue with yellow coating and a wiry and rapid pulse. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency, and liver fire disturbing the heart.
After 7 doses (one dose per day) of the medicine (formula example 1) are taken, all symptoms are relieved, the patient can better turn before falling asleep, the mouth is still dry, the stool is normal, the frequent micturition is caused at night, and the lower limbs are afraid of cold. After the original formula is continuously taken for 7 days, all symptoms are obviously improved, and the sleep is obviously improved. The composition is administered continuously to consolidate the treatment.
Case 13 Liu Yi Yu, male, age 54.
Complaining about insomnia for 2 years. Difficulty in falling asleep, easy to wake up after sleep, insomnia after waking up, vexation, belch, chest distress, abdominal fullness, hiccup, heavy head, blurred vision, and restlessness in lying. A reddish tongue with yellow and greasy coating and a slippery and rapid pulse. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency, and phlegm-heat disturbing the heart.
After 7 doses (one dose per day) of the medicine (formula example 1), all symptoms are improved, and the sleep is improved better. The medicine is continuously taken in the front to consolidate the treatment.
Case 14 Liu someping, male, age 59.
The patients have the symptoms of insomnia of 1 year, difficulty in falling asleep, easy waking up after sleeping, irritability, dreaminess, palpitation, amnesia, mental fatigue, anorexia, dizziness, lusterless complexion, lassitude of limbs, abdominal distension and loose stool. The history of hypertension is 10 years, diabetes is 10 years, and hyperlipidemia is 3 years. A pale tongue with thin coating and a thready and weak pulse. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency.
After 7 doses (one dose per day) of the medicine (formula example 1), the symptoms are improved, no dreams occur, the spirit and the fatigue are improved, the excrement is normal, the abdominal distension does not occur, and the sleep is improved. The original prescription is continued to take for consolidation treatment.
Case 15 li-bi, female, 79 years old.
Complaining about insomnia for 5 years. Poor sleep quality, easy to fall asleep, but easy to wake up after sleeping, difficult to fall asleep after waking up, shallow sleep, dysphoria with smothery sensation in chest, dreaminess, dizziness, tinnitus, soreness and weakness of waist and knees, night sweat, dry throat and dry mouth. The history of coronary heart disease is 8 years. The tongue is red with little coating and the pulse is thready and rapid. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency, disharmony between heart and kidney.
After 7 doses (one dose per day) of the medicine (formula example 1), all symptoms are improved, and the sleep is improved better.
Case 16 week old, female, age 52.
Complaining about insomnia for 2 years. Insomnia and dreaminess, easy waking after sleeping, insomnia after waking, insomnia all the night, irritability, vexation, dizziness, tinnitus, dry mouth, bitter taste, anorexia, constipation, and frequent micturition at night. A red tongue with yellow coating and a wiry and rapid pulse. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency, and liver fire disturbing the heart.
After 7 doses (one dose per day) of the medicine (formula example 1) are taken, all symptoms are relieved, the patient can better turn to sleep, the mouth is still dry, the stool is normal, and the frequent micturition at night is still realized. After the original formula is taken for 7 days, all symptoms are improved obviously, and the symptoms are improved before the patient falls asleep.
Case 17 wangzheng show, female, 56 years old.
Complaining about insomnia for 3 years. Difficulty in falling asleep, easy awakening after sleep, dreaminess, vexation, dizziness, tinnitus, dysphoria with feverish sensation in chest, palms and soles, night sweat, dry mouth and throat, gingival loosening, soreness and weakness of waist and knees, cold lower limbs, frequent micturition at night, dry stool. The tongue is red with little coating and the pulse is thready and rapid. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency, disharmony between heart and kidney.
After 7 doses (one dose per day) of the medicine (formula example 1), all the symptoms are improved, but the lower limbs are still cool, frequent urination at night and dry stools. After the original formula is continuously taken for 7 days, all symptoms are obviously improved, but the lower limbs are still cool, the urine is frequent at night, and the sleep is obviously improved. The original prescription is continued to take for consolidation treatment.
Case 18 adult, female, age 74.
Complaining about insomnia for 2 years. Difficulty in falling asleep, dreaminess and easy wakefulness, difficulty in falling asleep after waking up, irritability, dry eyes, dizziness and eye distension, mental fatigue and hypodynamia, poor appetite, lassitude of limbs, loose stool and frequent urination. The history of hypertension is 20 years, the number of heart stents is 2, and the history of diabetes is 11 years. Dark tongue with thin coating and wiry, thready and weak pulse. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency.
After 7 doses (one dose per day) of the medicine (formula example 1) are taken, the symptoms are improved, and the sleep is better than before.
Case 19 Zhang some river, male, age 76.
Complain about difficulty falling asleep for 3 years. Difficulty in falling asleep, easy to wake up after sleep, dreaminess, irritability, vexation, dry mouth, bitter taste, dysphoria with feverish sensation in the chest, dry throat, scanty body fluid, soreness of waist, frequent nocturia, dry stool and urine. The history of hypertension is 3 years. The tongue is red with little coating and the pulse is thready and rapid. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency.
After 7 doses (one dose per day) of the medicine (formula example 1), all symptoms are improved, and the symptoms still include dry throat, dysphoria with feverish sensation in chest, palms and soles, frequent urination at night and dry stool. After the original formula is continuously taken for 7 days, all symptoms are obviously improved, and the frequent urination and the dry stool are still remained. The original prescription is continued to take for consolidation treatment.
Complaining about insomnia for 1 year. Frequent insomnia, difficulty in falling asleep or easy waking after sleeping, dreaminess, irritability, tinnitus, dry throat, soreness and weakness of waist and knees, dysphoria with feverish sensation in the chest, dry skin, frequent urination at night, dry stool. The history of hypertension is 10 years. The tongue is red with little coating and the pulse is thready and rapid. And (3) diagnosis: insomnia, liver stagnation, spleen deficiency, and kidney yin deficiency.
After 7 doses (one dose per day) of the medicine (formula example 1), all symptoms are improved, and the symptoms still include dry throat, dysphoria with feverish sensation in chest, palms and soles, frequent urination at night and dry stool. The original prescription is continued to take for consolidation treatment.
Case 21 wangzhi, male, age 55.
Complaining about insomnia for 2 years. Easy to wake up after sleeping, difficult to fall asleep after waking up, dreaminess, vexation, timidity, palpitation, easy to fright when touching, shortness of breath, spontaneous perspiration, lassitude and hypodynamia. Pale tongue and wiry and thready pulse. And (3) diagnosis: insomnia, liver stagnation, spleen deficiency, heart deficiency, timidity.
After 7 doses (one dose per day) of the medicine (formula example 1), all symptoms are improved, but the symptoms are listlessness, hypoappetite and limb lassitude. After the original formula is continuously taken for 7 days, the symptoms are obviously improved, the spirit is tired, the fatigue is reduced, the appetite is poor, the limbs are tired, the sleep is improved. The original prescription is continued to take for consolidation treatment.
Case 22, korea, male, age 48.
Complaining about insomnia for 3 months. Easy to wake up after sleeping, difficult to fall asleep after waking up, dreaminess, vexation, timidity, palpitation, easy to fright when touching, shortness of breath, spontaneous perspiration, lassitude and hypodynamia. Pale tongue and wiry and thready pulse. And (3) diagnosis: insomnia, liver stagnation, spleen deficiency, and qi deficiency of heart and gallbladder.
After 7 doses (one dose per day) of the medicine (formula example 1) are taken, the symptoms are relieved, the patient can better turn to sleep before going to sleep, the mouth is still dry, the stool is normal, the night is frequent, and the lower limbs are afraid of cold. After the original formula is continuously taken for 7 days, the symptoms are relieved, the patients are improved obviously before falling asleep, nocturia is frequent, and lower limbs are afraid of cold. The original prescription is continued to take for consolidation treatment.
Case 23, a bell, female, 56 years old.
Complaining about insomnia for 3 years. Easy waking up after sleeping, insomnia after waking up, dreaminess, listlessness, hypodynamia, anorexia, lassitude of limbs, dizziness, palpitation, short breath, sigh, loose stool and frequent urination at night. Dark tongue with thin coating and wiry, thready and weak pulse. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency.
After 7 doses of the medicine (formula example 1) are taken (one dose per day), the symptoms are improved, and the sleep is obviously improved. The original prescription is continued to take orally, and the treatment is consolidated.
Case 24 guo, female, 72 years old.
Complaining about insomnia for 3 years. Difficulty in falling asleep, easy waking after sleep, dreaminess, vexation, accompanied by dizziness, tinnitus, dysphoria with feverish sensation in the chest, night sweat, dry mouth and throat, soreness and weakness of waist and knees, upper half sweating, cold lower limbs, frequent micturition at night, dry stool. The tongue is red with little coating and the pulse is thready and rapid. And (3) diagnosis: insomnia, liver stagnation, spleen deficiency, disharmony between heart and kidney.
After 7 doses (one dose per day) of the medicine (formula example 1), all the symptoms are improved, but the lower limbs are still cool, frequent urination at night and dry stools. After the original formula is continuously taken for 7 days, various symptoms are obviously improved, and the sleep is good.
Case 25 Ning certain Ju, female, 53 years old.
Complaining about difficulty falling asleep for 5 months. The patient is easy to wake up after sleeping, is difficult to fall asleep after waking up, is dreamful, gets worse day by day, and is even sleepless all night, impatient and irritability, accompanied by dizziness and eye swelling, dry mouth and bitter taste, poor appetite, aphthous stomatitis and tongue, and dry stool. A red tongue with yellow coating and a wiry and rapid pulse. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency, and liver fire disturbing the heart.
After 7 doses (one dose per day) of the medicine (formula example 1) are taken, all symptoms are relieved, the patient can be better before falling asleep, and the diet is not good enough. The original prescription is continued to take orally, and the treatment is consolidated.
Case 26 hanzhixiang, female, 73 years old.
Complaining about insomnia for 3 years. Difficulty in falling asleep, easy waking after sleep, dreaminess, vexation, accompanied by dizziness, tinnitus, dysphoria with feverish sensation in the chest, night sweat, dry mouth and throat, soreness and weakness of waist and knees, upper half sweating, cold lower limbs, frequent micturition at night, dry stool. The tongue is red with little coating and the pulse is thready and rapid. And (3) diagnosis: insomnia, liver stagnation, spleen deficiency, disharmony between heart and kidney.
After 7 doses (one dose per day) of the medicine (formula example 1) are taken, all the symptoms are improved, but the lower limbs are still cold, frequent urination at night and dry stool. After the original formula is continuously taken for 7 days, all symptoms are obviously improved, the sleep is good, and the stool is normal.
Case 27 jiaozao, male, age 30.
Complaining of insomnia for 2 months. Easy to wake up after sleeping, difficult to fall asleep after waking up, dreaminess, vexation, timidity, palpitation, easy to fright when touching an event, accompanied by shortness of breath, spontaneous perspiration, lassitude and hypodynamia. Pale tongue and wiry and thready pulse. And (3) diagnosis: insomnia, liver stagnation, spleen deficiency, and qi deficiency of heart and gallbladder.
After 7 doses (one dose per day) of the medicine (formula example 1), all symptoms are improved, but the symptoms are listlessness, hypoappetite and limb lassitude. After the original formula is continuously taken for 7 days, various symptoms are obviously improved, and the sleep is obviously improved. The original prescription is continued to be taken orally, and the treatment is consolidated.
Case 28 Rong certain treasure, female, 73 years old.
Complaining about insomnia for 3 years. Difficulty in falling asleep, easy waking after sleep, dreaminess, vexation, accompanied by dizziness, tinnitus, dysphoria with feverish sensation in the chest, night sweat, dry mouth and throat, soreness and weakness of waist and knees, upper half sweating, cold lower limbs, frequent micturition at night, dry stool. The tongue is red with little coating and the pulse is thready and rapid. And (3) diagnosis: insomnia, liver stagnation, spleen deficiency, disharmony between heart and kidney.
After 7 doses (one dose per day) of the medicine (formula example 1), all the symptoms are improved, but the lower limbs are still cool, frequent urination at night and dry stools. After the original formula is continuously taken for 7 days, all symptoms are obviously improved, but the lower limbs are still cool and the patient can sleep. The original prescription is continued to take orally, and the treatment is consolidated.
Case 29 continues for a deluxe, female, age 34.
Complaining of insomnia for 2 months. Poor sleep quality, easy to wake up after sleeping, insomnia after waking up, dreaminess, vexation, chest distress, epigastric fullness, nausea, belching, heavy head and blurred vision. The tongue is reddish, the coating is yellow and greasy, and the pulse is slippery and rapid. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency, and phlegm-heat disturbing the heart.
After 7 doses of the medicine (formula example 1) (one dose per day), various symptoms are obviously improved.
Case 30 one kind of a diet, female, 56 years old.
Complaining about the difficulty in falling asleep for 4 years. Difficulty in falling asleep, easy to wake up after sleeping, difficulty in falling asleep after waking up, dreaminess, gradual aggravation, insomnia all night, irritability, dizziness, fullness of the eyes, dry mouth, bitter taste, poor appetite, aphtha of the mouth and tongue, and dry stool. The tongue is red with yellow coating and the pulse is wiry and rapid. And (3) diagnosis: insomnia, liver stagnation and spleen deficiency, and phlegm-heat disturbing the heart.
After 7 doses (one dose per day) of the medicine (formula example 1) are taken, all symptoms are relieved, the sleep is improved, and the mouth and the stool are still dry. The original prescription is continued to take orally, and the treatment is consolidated.
Claims (10)
1. A traditional Chinese medicine composition for treating liver-stagnation and spleen-deficiency type insomnia is characterized by comprising the following components in parts by weight: 200 to 250 parts of bupleurum, 125 to 175 parts of angelica, 125 to 175 parts of white peony root, 100 to 150 parts of mint, 125 to 175 parts of curcuma aromatica, 225 to 275 parts of cortex albiziae, 275 to 325 parts of poria cocos, 200 to 250 parts of bighead atractylodes rhizome, 200 to 250 parts of rhizoma pinellinae praeparata, 125 to 175 parts of ginger, 125 to 175 parts of gardenia, 125 to 175 parts of rhizoma anemarrhenae, 125 to 175 parts of fructus forsythiae, 275 to 325 parts of spina date seed, 225 to 275 parts of platycladi seed and 100 to 150 parts of honey-fried licorice root.
2. The traditional Chinese medicine composition for treating insomnia caused by liver depression and spleen deficiency as set forth in claim 1, which is characterized by comprising the following components in parts by weight: 225 parts of radix bupleuri, 150 parts of angelica, 150 parts of radix paeoniae alba, 125 parts of mint, 150 parts of radix curcumae, 250 parts of cortex albiziae, 300 parts of poria cocos, 225 parts of rhizoma atractylodis macrocephalae, 225 parts of rhizoma pinellinae praeparata, 150 parts of ginger, 150 parts of cape jasmine, 150 parts of rhizoma anemarrhenae, 150 parts of fructus forsythiae, 300 parts of spina date seed, 250 parts of platycladi seed and 125 parts of radix glycyrrhizae preparata.
3. The traditional Chinese medicine composition for treating insomnia caused by liver depression and spleen deficiency as claimed in claim 1 or 2, which is prepared by the following method:
(1) Weighing the medicinal materials according to the weight ratio;
(2) Decocting bupleuri radix, radix Angelicae sinensis, radix Paeoniae alba, radix Curcumae, cortex Albizziae, poria, atractylodis rhizoma, rhizoma Pinelliae Preparata, rhizoma Zingiberis recens, fructus Gardeniae, rhizoma anemarrhenae, fructus forsythiae, semen Ziziphi Spinosae, semen Platycladi and radix Glycyrrhizae Preparata with 6 times of water, extracting for 100 to 110 minutes, adding herba Menthae, extracting for 10 to 20 minutes, and filtering;
(3) Adding 6 times of water into the solid filtered in the step (2), decocting, extracting for 85 to 95 minutes, and filtering;
(4) Mixing the filtrates in the step (2) and the step (3), and concentrating under reduced pressure to obtain a clear paste with the relative density of 1.05-1.16;
(5) And spray drying the clear paste to obtain spray dry powder.
4. The traditional Chinese medicine composition for treating insomnia caused by liver depression and spleen deficiency as claimed in claim 3, wherein in step (2), radix bupleuri, angelica sinensis, radix paeoniae alba, radix curcumae, cortex albiziae, poria cocos, rhizoma atractylodis macrocephalae, rhizoma pinellinae praeparata, ginger, fructus gardeniae, rhizoma anemarrhenae, fructus forsythiae, semen ziziphi spinosae, semen boitae and radix glycyrrhizae preparata are decocted by adding 6 times of water, mint is added when extraction is carried out for 105 minutes, extraction is carried out for 15 minutes, and filtration is carried out.
5. The traditional Chinese medicine composition for treating insomnia caused by liver depression and spleen deficiency as claimed in claim 3, wherein in step (3), the filtered solid obtained in step (2) is added with 6 times of water for decoction, extraction is carried out for 90 minutes, and filtration is carried out.
6. The traditional Chinese medicine composition for treating insomnia caused by liver depression and spleen deficiency as claimed in claim 3, wherein in the step (4), the vacuum degree of the reduced pressure concentration is 0.06 to 0.08MPa.
7. The traditional Chinese medicine composition for treating insomnia caused by liver depression and spleen deficiency as claimed in claim 3, wherein in the step (5), the air inlet temperature during spray drying is 170 to 180 ℃, and the air outlet temperature is 75 to 85 ℃.
8. A preparation comprising the traditional Chinese medicine composition for treating insomnia caused by liver depression and spleen deficiency as set forth in any one of claims 1 to 7.
9. The formulation according to claim 8, characterized in that it is a powder comprising 498 to 682 parts by weight of spray dry powder and the complement 1000 parts by weight of dextrin.
10. The preparation according to claim 9, which is a granule, wherein the spray dry powder and the dextrin are mixed uniformly and then dry granulated, and the 10 to 50-mesh granules are collected.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211125375.1A CN115400199A (en) | 2022-09-15 | 2022-09-15 | Traditional Chinese medicine composition for treating liver-stagnation and spleen-deficiency type insomnia and preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211125375.1A CN115400199A (en) | 2022-09-15 | 2022-09-15 | Traditional Chinese medicine composition for treating liver-stagnation and spleen-deficiency type insomnia and preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115400199A true CN115400199A (en) | 2022-11-29 |
Family
ID=84165451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211125375.1A Pending CN115400199A (en) | 2022-09-15 | 2022-09-15 | Traditional Chinese medicine composition for treating liver-stagnation and spleen-deficiency type insomnia and preparation thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115400199A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104189727A (en) * | 2014-07-26 | 2014-12-10 | 杨建平 | Traditional Chinese medicine used for treating intermenstrual sentiment abnormality |
CN105194631A (en) * | 2015-11-02 | 2015-12-30 | 仲学龙 | Traditional Chinese medicine preparation for treating depression |
CN111671868A (en) * | 2020-05-11 | 2020-09-18 | 首都医科大学附属北京中医医院 | Traditional Chinese medicine composition for treating coronavirus pneumonia and insomnia |
-
2022
- 2022-09-15 CN CN202211125375.1A patent/CN115400199A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104189727A (en) * | 2014-07-26 | 2014-12-10 | 杨建平 | Traditional Chinese medicine used for treating intermenstrual sentiment abnormality |
CN105194631A (en) * | 2015-11-02 | 2015-12-30 | 仲学龙 | Traditional Chinese medicine preparation for treating depression |
CN111671868A (en) * | 2020-05-11 | 2020-09-18 | 首都医科大学附属北京中医医院 | Traditional Chinese medicine composition for treating coronavirus pneumonia and insomnia |
Non-Patent Citations (2)
Title |
---|
曹艺: "辨证分型治疗慢性肝病伴失眠浅识", 实用中医内科杂志, vol. 24, no. 10, pages 56 - 57 * |
陈文芳,等: "健康逍遥汤治疗亚健康失眠肝气郁结型失眠45例", 中医临床研究, vol. 05, no. 15, pages 89 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102078520B (en) | Chinese medicinal preparation for treating nervous headache and preparation method thereof | |
CN101856430A (en) | Green tonic lucid ganoderma (three immortals) cream for preventing sub-health and preparation method thereof | |
CN103341039B (en) | Nourishing formula for enhancing human body immunity and production method of soup thereof | |
CN104069335A (en) | Medicine composition capable of improving sleep quality and preparation method of medicine composition as well as application of medicine composition | |
CN103585479A (en) | Blood-replenishing pill and blood-replenishing capsule for treating iron-deficiency anemia | |
CN108355088A (en) | A kind of spina date seed medicinal liquor and preparation method thereof improving sleep quality | |
CN104547532A (en) | Traditional Chinese medicine preparation for treating migraine and preparation method of traditional Chinese medicine preparation | |
CN115350256B (en) | Traditional Chinese medicine composition for treating insomnia and preparation method thereof | |
CN105796845A (en) | Application of medicine composition in preparing medicine for treating female climacteric syndromes | |
CN105456818A (en) | Traditional Chinese medicine composition containing folium artemisiae argyi and being capable of treating insomnia and preparation method of traditional Chinese medicine composition | |
CN105497789A (en) | Traditional Chinese medicine preparation for treating poststroke depression and preparation method of traditional Chinese medicine preparation | |
CN115487239A (en) | Pharmaceutical composition for treating insomnia with anxiety and depression and preparation method thereof | |
CN104524292A (en) | Application of traditional Chinese medicine preparation in preparation of medicament for treating obesity | |
CN115400199A (en) | Traditional Chinese medicine composition for treating liver-stagnation and spleen-deficiency type insomnia and preparation thereof | |
CN113750184A (en) | Traditional Chinese medicine composition for soothing nerves and helping sleep and preparation method thereof | |
CN106620475B (en) | Traditional Chinese medicine composition for preventing and treating diabetes cognitive impairment and preparation method thereof | |
CN112915175A (en) | Anti-fatigue traditional Chinese medicine composition tablet and preparation method thereof | |
CN114081171A (en) | Functional food composition with function of assisting in improving sleep | |
CN112023010A (en) | Traditional Chinese medicine composition for slimming, preparation method thereof, oral medicine and application | |
CN105362630A (en) | Climacteric syndrome treatment pharmaceutical composition and preparation method thereof | |
CN105797034A (en) | Method for preparing traditional Chinese medicinal composition for treating steatohepatitis complicated with hyperlipidemia | |
CN110638937A (en) | Traditional Chinese medicine for treating insomnia | |
CN104162090B (en) | Pharmaceutical composition and preparation method thereof | |
CN110420313A (en) | A kind of production technology and its method of donkey-hide gelatin ginseng drink | |
CN115737746B (en) | Medicine-food homologous spleen-invigorating soup improvement material, preparation method thereof, medicine and food composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221129 |